257
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood–brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies

, , , &
Pages 685-693 | Received 24 Oct 2013, Accepted 31 Mar 2014, Published online: 25 Jun 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kiran Jyoti, Om Prakash Katare, Anjoo Kamboj & Jitender Madan. (2020) Protamine sulphate coated poly (lactide-co-glycolide) nanoparticles of MUC-1 peptide improved cellular uptake and cytokine release in mouse antigen presenting cells. Journal of Microencapsulation 37:8, pages 566-576.
Read now

Articles from other publishers (13)

Paula Alfonso-Triguero, Julia Lorenzo, Ana Paula Candiota, Carles Arús, Daniel Ruiz-Molina & Fernando Novio. (2023) Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?. Nanomaterials 13:10, pages 1619.
Crossref
Etikala Amulya, Anupama Sikder, Ganesh Vambhurkar, Saurabh Shah, Dharmendra Kumar Khatri, Rajeev Singh Raghuvanshi, Shashi Bala Singh & Saurabh Srivastava. (2023) Nanomedicine based strategies for oligonucleotide traversion across the blood–brain barrier. Journal of Controlled Release 354, pages 554-571.
Crossref
Seyed Mohammad Hossein Dabiri, Tavia Walsh, Amir Barzegar Behrooz, Vinith Yathindranath, Courtney Clark, Samira Aghajani, Mazaher Ahmadi, Tayyebeh Madrakian, Donald W. Miller & Saeid Ghavami. 2023. New Insights Into Glioblastoma. New Insights Into Glioblastoma 631 665 .
William M. Pardridge. (2022) A Historical Review of Brain Drug Delivery. Pharmaceutics 14:6, pages 1283.
Crossref
Morgane Renault-Mahieux, Victoire Vieillard, Johanne Seguin, Philippe Espeau, Dang Tri Le, René Lai-Kuen, Nathalie Mignet, Muriel Paul & Karine Andrieux. (2021) Co-Encapsulation of Fisetin and Cisplatin into Liposomes for Glioma Therapy: From Formulation to Cell Evaluation. Pharmaceutics 13:7, pages 970.
Crossref
. 2021. Nanomaterials: Evolution and Advancement towards Therapeutic Drug Delivery (Part II). Nanomaterials: Evolution and Advancement towards Therapeutic Drug Delivery (Part II) 246 292 .
Mo’tasem M. Alsmadi, Rana M. Obaidat, Mohammad Alnaief, Borhan Aldeen Albiss & Nabil Hailat. (2020) Development, In Vitro Characterization, and In Vivo Toxicity Evaluation of Chitosan-Alginate Nanoporous Carriers Loaded with Cisplatin for Lung Cancer Treatment. AAPS PharmSciTech 21:5.
Crossref
Khaled S. Shamarekh, Heba A. Gad, Mahmoud E. Soliman & Omaima A. Sammour. (2020) Development and evaluation of protamine-coated PLGA nanoparticles for nose-to-brain delivery of tacrine: In-vitro and in-vivo assessment. Journal of Drug Delivery Science and Technology 57, pages 101724.
Crossref
Basant Salah Mahmoud, Ali Hamod AlAmri & Christopher McConville. (2020) Polymeric Nanoparticles for the Treatment of Malignant Gliomas. Cancers 12:1, pages 175.
Crossref
Xiaowen Zhu, Kai Jin, Yilan Huang & Zhiqing Pang. 2019. Brain Targeted Drug Delivery System. Brain Targeted Drug Delivery System 159 183 .
Sabrina Rossi, Giovanna Finocchiaro, Silvia Marchetti, Luca Toschi & Armando Santoro. (2018) Checkpoint inhibitors: ‘raising the bar’ also in brain metastases from non-small-cell lung cancer?. Immunotherapy 10:5, pages 403-410.
Crossref
Ahmed O. Elzoghby, Shaimaa K. Mostafa, Maged W. Helmy, Maha A. ElDemellawy & Salah A. Sheweita. (2017) Superiority of aromatase inhibitor and cyclooxygenase-2 inhibitor combined delivery: Hyaluronate-targeted versus PEGylated protamine nanocapsules for breast cancer therapy. International Journal of Pharmaceutics 529:1-2, pages 178-192.
Crossref
Mauricio P Pinto, Maximiliano Arce, Basit Yameen & Cristian Vilos. (2017) Targeted brain delivery nanoparticles for malignant gliomas. Nanomedicine 12:1, pages 59-72.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.